TY - JOUR
T1 - An organoid biobank for childhood kidney cancers that captures disease and tissue heterogeneity
AU - Calandrini, Camilla
AU - Schutgens, Frans
AU - Oka, Rurika
AU - Margaritis, Thanasis
AU - Candelli, Tito
AU - Mathijsen, Luka
AU - Ammerlaan, Carola
AU - van Ineveld, Ravian L
AU - Derakhshan, Sepide
AU - de Haan, Sanne
AU - Dolman, Emmy
AU - Lijnzaad, Philip
AU - Custers, Lars
AU - Begthel, Harry
AU - Kerstens, Hindrik H D
AU - Visser, Lindy L
AU - Rookmaaker, Maarten
AU - Verhaar, Marianne
AU - Tytgat, Godelieve A M
AU - Kemmeren, Patrick
AU - de Krijger, Ronald R
AU - Al-Saadi, Reem
AU - Pritchard-Jones, Kathy
AU - Kool, Marcel
AU - Rios, Anne C
AU - van den Heuvel-Eibrink, Marry M
AU - Molenaar, Jan J
AU - van Boxtel, Ruben
AU - Holstege, Frank C P
AU - Clevers, Hans
AU - Drost, Jarno
PY - 2020/3/11
Y1 - 2020/3/11
N2 - Kidney tumours are among the most common solid tumours in children, comprising distinct subtypes differing in many aspects, including cell-of-origin, genetics, and pathology. Pre-clinical cell models capturing the disease heterogeneity are currently lacking. Here, we describe the first paediatric cancer organoid biobank. It contains tumour and matching normal kidney organoids from over 50 children with different subtypes of kidney cancer, including Wilms tumours, malignant rhabdoid tumours, renal cell carcinomas, and congenital mesoblastic nephromas. Paediatric kidney tumour organoids retain key properties of native tumours, useful for revealing patient-specific drug sensitivities. Using single cell RNA-sequencing and high resolution 3D imaging, we further demonstrate that organoid cultures derived from Wilms tumours consist of multiple different cell types, including epithelial, stromal and blastemal-like cells. Our organoid biobank captures the heterogeneity of paediatric kidney tumours, providing a representative collection of well-characterised models for basic cancer research, drug-screening and personalised medicine.
AB - Kidney tumours are among the most common solid tumours in children, comprising distinct subtypes differing in many aspects, including cell-of-origin, genetics, and pathology. Pre-clinical cell models capturing the disease heterogeneity are currently lacking. Here, we describe the first paediatric cancer organoid biobank. It contains tumour and matching normal kidney organoids from over 50 children with different subtypes of kidney cancer, including Wilms tumours, malignant rhabdoid tumours, renal cell carcinomas, and congenital mesoblastic nephromas. Paediatric kidney tumour organoids retain key properties of native tumours, useful for revealing patient-specific drug sensitivities. Using single cell RNA-sequencing and high resolution 3D imaging, we further demonstrate that organoid cultures derived from Wilms tumours consist of multiple different cell types, including epithelial, stromal and blastemal-like cells. Our organoid biobank captures the heterogeneity of paediatric kidney tumours, providing a representative collection of well-characterised models for basic cancer research, drug-screening and personalised medicine.
KW - Adolescent
KW - Biological Specimen Banks
KW - Carcinoma, Renal Cell/drug therapy
KW - Cell Culture Techniques/methods
KW - Child
KW - Child, Preschool
KW - DNA Methylation
KW - Drug Screening Assays, Antitumor/methods
KW - Female
KW - Gene Expression Regulation, Neoplastic
KW - Genetic Heterogeneity
KW - Genotyping Techniques
KW - Humans
KW - Infant
KW - Kidney/pathology
KW - Kidney Neoplasms/drug therapy
KW - Male
KW - Nephroma, Mesoblastic/drug therapy
KW - Netherlands
KW - Organoids/pathology
KW - Precision Medicine/methods
KW - RNA-Seq
KW - Rhabdoid Tumor/drug therapy
KW - Single-Cell Analysis
KW - Transfection
KW - Tumor Cells, Cultured
KW - Whole Genome Sequencing
KW - Wilms Tumor/drug therapy
KW - Young Adult
U2 - 10.1038/s41467-020-15155-6
DO - 10.1038/s41467-020-15155-6
M3 - Article
C2 - 32161258
SN - 2041-1723
VL - 11
JO - Nature Communications
JF - Nature Communications
IS - 1
M1 - 1310
ER -